Evidence map›Paper›PMID 37025944›Full record

ArticleJHEP reports : innovation in hepatology2023

Low haemoglobin level predicts early hospital readmission in patients with cirrhosis and acute decompensation.

Enrico Pompili, Maurizio Baldassarre, Giacomo Zaccherini, Manuel Tufoni, Giulia Iannone, Dario Pratelli, Francesco Palmese, Luca Vizioli, Chiara Faggiano, Giorgio Bedogni and 2 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Personalised Long-Term Albumin Treatment Based on Three-Month Ascites Response in Patients With Decompensated Cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2026
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Enrico PompiliDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Maurizio BaldassarreDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Giacomo ZaccheriniDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Manuel TufoniUnit of Semeiotics, Liver and Alcohol-related Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Giulia IannoneDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Dario PratelliDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Francesco PalmeseDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Luca VizioliInternal Medicine Unit for the Treatment of Severe Organ Failure, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Chiara FaggianoDivision of Internal Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Giorgio BedogniDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Marco DomenicaliDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Paolo CaraceniDepartment of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
University of Bologna · ITAzienda USL di Bologna · ITOspedale "Santa Maria delle Croci" di Ravenna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Patients with decompensated cirrhosis present frequent hospitalisations with a relevant clinical and socio-economic impact. This study aims to characterise unscheduled readmissions up to 1-year follow-up and identify predictors of 30-day readmission after an index hospitalisation for acute decompensation (AD). Methods: We performed a secondary analysis of a prospectively collected cohort of patients admitted for AD. Laboratory and clinical data at admission and at discharge were collected. Timing and causes of unscheduled readmissions and mortality were recorded up to 1 year. Results: A total of 329 patients with AD were included in the analysis. Acute-on-chronic liver failure was diagnosed in 19% of patients at admission or developed in an additional 9% of patients during the index hospitalisation. During the 1-year follow-up, 182 patients (55%) were rehospitalised and 98 (30%) more than once. The most frequent causes of readmission were hepatic encephalopathy (36%), ascites (22%), and infection (21%). Cumulative incidence of readmission was 20% at 30 days, 39% at 90 days, and 63% at 1 year. Fifty-four patients were readmitted for emergent liver-related causes within 30 days. Early readmission was associated with a higher 1-year mortality (47 Conclusion: Besides MELD-Na, a low Hb level (Hb ≤8.7 g/dl) at discharge emerged as a new risk factor for early readmission, contributing to identification of patients who require closer surveillance after discharge. Impact and Implications: Patients with decompensated cirrhosis face frequent hospitalisations. In the present study, type and causes of readmissions were analysed during 1-year follow-up in patients discharged after the index hospitalisation for an acute decompensation of the disease. Early (30-day) liver-related readmission was associated with higher 1-year mortality. The model for end-stage liver disease-sodium score and low haemoglobin at discharge were identified as independent risk factors for early readmissions. Haemoglobin emerged as a new easy-to-use parameter associated with early readmission warranting further investigation.

Indexed as

AnaemiaEarly readmissionHaemoglobinHospitalisationLiver cirrhosisMELD scoreSystemic inflammation

Identifiers

PMID37025944
PMCPMC10070139
OpenAlexW4320035106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.